e-learning
resources
Munich 2014
Sunday, 07.09.2014
The assessment of comorbidities
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Lung cancer screening in COPD patients: NLST criteria vs a COPD screening score
J. de Torres, D. Wilson, P. Sanchez, J. Weissfeld, A. B. Alcaide, A. Campo, U. Montes, J. Zulueta (Pamplona, Spain; Pittsburgh, United States Of America)
Source:
International Congress 2014 – The assessment of comorbidities
Session:
The assessment of comorbidities
Session type:
Thematic Poster Session
Number:
976
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. de Torres, D. Wilson, P. Sanchez, J. Weissfeld, A. B. Alcaide, A. Campo, U. Montes, J. Zulueta (Pamplona, Spain; Pittsburgh, United States Of America). Lung cancer screening in COPD patients: NLST criteria vs a COPD screening score. Eur Respir J 2014; 44: Suppl. 58, 976
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Related content which might interest you:
Improving NLST criteria for lung cancer screening
Source: International Congress 2014 – Improving diagnosis of thoracic tumours
Year: 2014
Feasibility of lung cancer screening in a population of patients with emphysema and/or COPD meeting NLST criteria
Source: International Congress 2015 – Diagnosis and therapy of lung cancer
Year: 2015
Prevalence of COPD and emphysema at the time of diagnosis of primary lung cancer
Source: International Congress 2014 – Epidemiology, pathogenesis and quality management of thoracic tumours
Year: 2014
Incidence of lung cancer in smokers with and without COPD: Observational study
Source: Annual Congress 2013 –Pathogenesis and risk of lung cancer
Year: 2013
Lung cancer in COPD patients on home oxygen-therapy
Source: International Congress 2016 – Epidemiology and specific subgroups in lung cancer
Year: 2016
Psychological assessment in COPD and lung cancer patients in pulmonary rehabilitation
Source: International Congress 2015 – Latest insights in pulmonary rehabilitation and functional capacity
Year: 2015
Eligibility for lung cancer screening in Australia and the effect on screening eligibility of using spirometry to identify COPD
Source: International Congress 2016 – Highlights in the management of COPD and beyond
Year: 2016
Lung volume reduction effect after lobectomy in COPD patients
Source: Annual Congress 2013 –Lung surgery: preoperative assessment and postoperative outcome
Year: 2013
Prospective assessment of incidental respiratory symptoms in COPD (PAIRS-COPD), feasibility study
Source: International Congress 2014 – Diagnosis, imaging and surgery for thoracic tumours
Year: 2014
Lung function in the elderly patients with a diagnosis of lung cancer - A challenge for the surgical treatment?
Source: International Congress 2015 – Surgery and lung cancer: results and complications
Year: 2015
Incidence and clinical characteristics of lung cancer in patients with COPD - From Hokkaido COPD cohort study
Source: International Congress 2016 – Recent high impact findings regarding COPD comorbidities
Year: 2016
Lower rate of COPD exacerbations in patients with COPD and concurrent lung carcinoma – Data from the Bergmannsheil cohort
Source: International Congress 2015 – Asthma and COPD: overlap and exacerbations
Year: 2015
Lung cancer screening in COPD patients.
Source: International Congress 2018 – Interdependence of COPD and comorbidities and the underlying mechanisms
Year: 2018
Lung cancer after lymphoma: Disease characteristics, detection methods and clinical outcome
Source: Annual Congress 2013 –Other thoracic tumours, particular circumstances and rare cases
Year: 2013
Lung cancer and lung tuberculosis: Our results of treatment in the combined lung disease
Source: International Congress 2016 – Surgical strategy for complex diseases
Year: 2016
Lung clearance index in pediatric patients with asthma
Source: Annual Congress 2013 –Asthma treatment and management in children
Year: 2013
Lung clearance index is increased in patients with COPD
Source: International Congress 2015 – Monitoring and phenotyping COPD
Year: 2015
COPD and lung cancer: Prevalence, infradiagnosis, phenotypes and multidimensional characterization
Source: International Congress 2016 – Epidemiology and specific subgroups in lung cancer
Year: 2016
Australia-modified Karnofsky performance scale in patients with COPD and lung cancer patients: A pooled data analysis
Source: International Congress 2016 – Best abstracts in COPD management
Year: 2016
Age related influence of COPD on postoperative pulmonary morbidity in lung cancer patients
Source: Annual Congress 2013 –Oncological thoracic surgery
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept